IHH Healthcare BhdXKLS:5225 +1.99%86 Net Margin % is 8.06% as of Mar. 2026, which is 4% below its 10-year median of 8.39. GuruFocus rates XKLS:5225 with a GF Score™ of 86/100 and a GF Value™ of RM8.07 (Fairly Valued). The stock has 11 warning signs investors should review. Among 668 Healthcare Providers & Services companies, IHH Healthcare Bhd ranks better than 72.46% on this metric.
The historical rank and industry rank for IHH Healthcare Bhd's Net Margin % or its related term are showing as below:
XKLS:5225'
s Net Margin % Range Over the Past 10 Years
Min: 2.16 Med: 8.39 Max: 14.1
Current: 8.13
XKLS:5225's Net Margin % is ranked better than 72.46% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs XKLS:5225: 8.13
IHH Healthcare Bhd (XKLS:5225) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
IHH Healthcare Bhd Net Margin % Related Terms
IHH Healthcare Bhd Net Margin % Historical Data
* Premium members only.
The historical data trend for IHH Healthcare Bhd's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:5225 vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, IHH Healthcare Bhd's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IHH Healthcare Bhd Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, IHH Healthcare Bhd's Net Margin % distribution charts can be found below:
* The bar in red indicates where IHH Healthcare Bhd's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IHH Healthcare Bhd (XKLS:5225) has a Net Margin % of 8.06% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on IHH Healthcare Bhd and its competitors. This is near median its historical median of 8.39. Over the past decade, IHH Healthcare Bhd's Net Margin % has ranged from 2.16 to 14.10. According to the industry distribution chart, IHH Healthcare Bhd ranks #184 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 27.5%.
Is IHH Healthcare Bhd's Net Margin % too high?
IHH Healthcare Bhd's current Net Margin % of 8.06% is near median its 10-year median of 8.39. Over the past 10 years, this metric has ranged from a low of 2.16 to a high of 14.10. The Healthcare Providers & Services industry median Net Margin % is 2.89. IHH Healthcare Bhd's value of 8.06% is 179.4% above this industry median. Based on the distribution chart, IHH Healthcare Bhd ranks #184 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, IHH Healthcare Bhd has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IHH Healthcare Bhd's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, IHH Healthcare Bhd ranks #184 out of 668 companies for Net Margin %. This puts IHH Healthcare Bhd in the upper half of its industry. The industry median Net Margin % is 2.89. IHH Healthcare Bhd's value of 8.06% is 179.4% above this benchmark. Historically, IHH Healthcare Bhd's own Net Margin % has ranged from 2.16 to 14.10 over the past decade. While the company's 10-year median is 8.39 vs. the industry median of 2.89, IHH Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IHH Healthcare Bhd's current Net Margin % of 8.06% is 179.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on IHH Healthcare Bhd and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IHH Healthcare Bhd's current Net Margin % is 8.06%, which is near median its own 10-year median of 8.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IHH Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, IHH Healthcare Bhd (XKLS:5225) is currently considered Fairly Valued. The stock's GF Value™ is RM8.07, compared to a current price of RM8.73 — trading 8.2% above its estimated fair value. The current Net Margin % is 8.06%, which is near median its 10-year median of 8.39 and 179.4% above the Healthcare Providers & Services industry median of 2.89. IHH Healthcare Bhd's overall GF Score™ is 86/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For IHH Healthcare Bhd (XKLS:5225), the current Net Margin % is 8.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IHH Healthcare Bhd (XKLS:5225) Overvalued in 2026?
Based on GuruFocus' analysis, IHH Healthcare Bhd stock appears to be overvalued.
The current stock price of RM8.73 is trading 8.2% above its estimated GF Value™ of RM8.07.
GuruFocus considers IHH Healthcare Bhd to be Fairly Valued.
Key valuation signals for XKLS:5225:
Net Margin %: 8.06% (near median its 10-year median of 8.39)
GF Value™: RM8.07 vs. price of RM8.73 (8.2% above fair value)
Industry Position: 179.4% above the Healthcare Providers & Services median (#184 of 668)
No single metric tells the full story. See the XKLS:5225 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IHH Healthcare Bhd is an investment holding company. Through its subsidiaries, it is a healthcare services provider that operates a network of hospitals. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The company's reportable segments include Healthcare services, Laboratories services, and Management fees. The majority of its revenue is generated from the Healthcare services segment, which relates to contracts with patients in which performance obligations are to provide healthcare services. Geographically, the company derives maximum revenue from Turkiye and Europe, followed by Singapore, Malaysia, India, Greater China, and Others.
86GF Score
Get the complete analysis for XKLS:5225
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5225 has been successfully added to your 
